However, without appropriate nutritional guidance and support from healthcare professionals, there is a real risk that reduced food intake could compromise dietary quality, meaning people may not get enough protein, fibre, vitamins, and minerals essential for maintaining overall health. Access to Treatment and Gaps in Care Guidance from the National Institute for Health and Care Excellence (NICE) recommends semaglutide as a weight management option for people who meet specific criteria, including a body mass index (BMI) of at least 35.0 kg/m2 and comorbidity (that is, they also have other conditions such as type 2 diabetes, cardiovascular disease, etc)
If cleared, CagriSema would become the first injectable to combine a GLP-1 receptor agonist with an amylin analogue, a genuine mechanistic milestone regardless of the comparison with tirzepatide
4 Danish Pharmacovigilance Council, Danish Medicines Agency, Copenhagen, Denmark Correspondence: Reimar W Thomsen, Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes All 43-45, 8200 Aarhus N, Denmark, Email [email protected] Purpose: A surge in the use of semaglutide injection (Ozempic ) approved to treat type 2 diabetes (T2D) has led to a global supply shortage
When symptoms occur, they usually relate to underlying conditionssuch as liver disease, kidney dysfunction, or haematological disordersthat cause the elevation
Yes, other companies are developing oral versions of GLP-1 and dual-acting drugs, though most are still in clinical trials
The pull: why people still try it The marketing hits three buttons fast
